TORNTPHARMNSETorrent Pharmaceuticals Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Wed, 8 Jul, 2026 · 10:21 IST

Torrent Pharma JB Chemicals amalgamation scheme effective from July 8

Listed Co AcquisitionNclt Scheme FiledStrategic Transactions View source PDFExplain this filing

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.6%Reaction day
₹4852.60
prior close
₹4905.00
announcement price
In-mkt
timing
Nifty 100market-2.1%+2.6% vs market
Pharmaceuticals peers, median of 165sector-0.8%+1.4% vs sector

On the reaction day the stock moved 2.6 pts more than Nifty 100 and 1.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.1
10m
-0.1
15m
-0.2
30m
+0.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.6-2.1+2.6-0.8+1.4
Next day
+0.8-1.7+2.4+0.0+0.8
2d
+0.8-0.6+1.4+0.5+0.3
3d
+1.9-0.7+2.6+1.0+1.0
4d
+2.5-1.3+3.8+0.2+2.3
5d
+3.1-1.1+4.2+0.8+2.2
1w
-2.2-0.3-1.9-0.3-1.9
15d
+0.5-0.4+0.9-0.4+1.0
1m
+1.5+1.3+0.2-0.3+1.7
2m
+2.2-2.4+4.6+3.1-0.9
3m
-4.9-8.4+3.6-1.5-3.4
UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 165Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The NCLT-approved amalgamation of JB Chemicals into Torrent Pharma became effective on 8 July 2026 after filing with the Registrar of Companies. Appointed date is 21 January 2026. JB Chemicals is now dissolved into Torrent Pharma. Torrent's MOA capital was updated to rupees 255.3 crore comprising 46.06 crore equity shares of rupees 5 each and 25 lakh preference shares of rupees 100 each.

Likely market impact

Merger now complete. JB Chemicals shareholders become Torrent Pharma shareholders. Expected cost and revenue synergies, expanded pharma footprint.